Back to SGMT

Affinity Asset Advisors, LLC → SGMT

Affinity Asset Advisors, LLC SGMT Position History

Sagimet Biosciences Inc. • Healthcare

Quarters held
4
Latest value
$25M
Q3 2026
Peak value
$25M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$6.8M
Q1 2026$4.5M
Q2 2026$19.3M
Q3 2026$25M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$25M2.53M——
Q2 2026$19.3M2.50M——
Q1 2026$4.5M868.0K——
Q4 2025$6.8M1.15M——

Other funds holding SGMT

Other Affinity Asset Advisors, LLC positions

ROIV

ROIVANT SCIENCES LTD

$132.7M
APGE

APOGEE THERAPEUTICS INC

$131M
ROIV

ROIVANT SCIENCES LTD

$117M
SYRE

SPYRE THERAPEUTICS INC

$113.9M
SYRE

SPYRE THERAPEUTICS INC

$113.6M
APGE

APOGEE THERAPEUTICS INC

$108.2M
XENE

XENON PHARMACEUTICALS INC

$97.4M
XENE

XENON PHARMACEUTICALS INC

$96.3M